EQT and owner family divest Fertin Pharma to Philip Morris International for DKK 5.1bn

Tobacco giant Philip Morris International buys Fertin Pharma from capital fund EQT and the Bagger-Sørensen family for DKK 5.1bn.
Photo: PR / Fertin Pharma
Photo: PR / Fertin Pharma

Private equity firm EQT and the Bagger-Sørensen family have sold the nicotine gum manufacturer Fertin Pharma to tobacco giant Philip Morris international, according to a Thursday press release naming the price at DKK 5.1bn (USD 813m).

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading